首页> 外文期刊>Medicine. >Efficacy and safety of therapeutic ERCP in patients with ectopic papilla of Vater
【24h】

Efficacy and safety of therapeutic ERCP in patients with ectopic papilla of Vater

机译:患者异位乳头患者治疗ERCP的疗效和安全性

获取原文
           

摘要

It remains challenging for endoscopists to manage pancreaticobiliary diseases in patients with ectopic papilla of Vater by endoscopic retrograde cholangiopancreatography ( ERCP ). The present study sought to evaluate the efficacy and safety of ERCP for this issue. Consecutive patients with ectopic papilla of Vater who underwent initial ERCP due to pancreaticobiliary diseases were retrospectively analyzed. One hundred seven patients with ectopic papilla of Vater were included. The success rate of cannulation was 83.2%. Endoscopic sphincterotomy, endoscopic papillary balloon dilation, and mechanical lithotripsy were performed in 12 (11.2%), 25 (23.4%), and 1 (0.9%) patients, respectively. The technical success rate was 83.2%; of these, endoscopic nasobiliary drainage, endoscopic retrograde biliary drainage, endoscopic retrograde pancreatic drainage, and stone extraction was conducted in 61 (57.0%), 17 (15.9%), 5 (4.7%), and 45 (42.1%) patients, respectively. Bile duct stone size ≥1 cm, number ≥2, and duodenum stenosis were risk factors for stone extraction inability. Adverse events occurred in 20 (18.7%) patients, including post- ERCP pancreatitis (3.7%), hyperamylasemia (12.1%), and infection of biliary tract (2.8%); all of the adverse events were mild and alleviated by conventional therapies. ERCP is an appropriate choice for pancreaticobiliary diseases in patients with ectopic papilla of Vater due to its high efficacy and safety. Bile duct stone size ≥1 cm, number ≥2, and duodenum stenosis increase difficulties for stone extraction.
机译:内窥镜手仍然具有挑战性,通过内镜逆行胆管痴呆(ERCP)来管理患者患者患者胰腺胆疾病。本研究试图评估ERCP为此问题的疗效和安全性。回顾性分析了由于胰腺癌疾病术后初始ERCP的vater异位乳头的连续患者。包括一百七名患者异位乳头患者。插管的成功率为83.2%。内窥镜晶状体切开术,内镜乳头状球囊扩张和机械型碎石分别在12(11.2%),25%(23.4%)和1(0.9%)患者中进行。技术成功率为83.2%;其中,内窥镜鼻血液引流,内窥镜逆行胆道引流,内窥镜逆行胰腺引流和石萃取分别在61(57.0%),17(15.9%),5(4.7%)和45名(42.1%)患者中进行。胆管石尺寸≥1厘米,数量≥2和十二指肠狭窄是石油提取无能的危险因素。不良事件发生在20名(18.7%)患者(包括ERCP后胰腺炎(3.7%),高亚亚血症(12.1%)和胆道感染(2.8%);所有不良事件都是温和的,并且通过常规疗法缓解。 ERCP is an appropriate choice for pancreaticobiliary diseases in patients with ectopic papilla of Vater due to its high efficacy and safety.胆管石尺寸≥1厘米,数量≥2和十二指肠狭窄增加了石头提取的困难。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号